A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
Administered By
Awarded By
Contributors
- Sudan, Debra L Principal Investigator
Start/End
- April 29, 2021 - February 28, 2026